7 insiders reported 37 Form 4 transactions for Replimune Group, Inc. (REPL) over the past 18 months (most recent 2026-06-03). Recent activity: Sarchi Christopher (Chief Commercial Officer) Sell 12,000 shares, Astley-Sparke Philip (Director) Sell 17,657 shares, Hill Emily Luisa (Chief Financial Officer) Sell 7,812 shares, Patel Sushil (Chief Executive Officer) Sell 37,324 shares, Xynos Konstantinos (Chief Medical Officer) Sell 14,023 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Sarchi Christopher | Chief Commercial Officer | Sell | 12,000 | $110,880 |
| 2026-05-20 | Astley-Sparke Philip | Director | Sell | 17,657 | $89,698 |
| 2026-05-20 | Hill Emily Luisa | Chief Financial Officer | Sell | 7,812 | $39,685 |
| 2026-05-20 | Patel Sushil | Chief Executive Officer | Sell | 37,324 | $189,606 |
| 2026-05-20 | Xynos Konstantinos | Chief Medical Officer | Sell | 14,023 | $71,237 |
| 2026-05-20 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,894 | $40,102 |
| 2026-05-20 | Sarchi Christopher | Chief Commercial Officer | Sell | 8,626 | $43,820 |
| 2026-04-07 | Astley-Sparke Philip | Director | Buy | 50,000 | $0 |
| 2026-04-07 | Hill Emily Luisa | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Patel Sushil | Chief Executive Officer | Buy | 251,240 | $0 |
| 2026-04-07 | Xynos Konstantinos | Chief Medical Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Schwendenman Andrew | Chief Accounting Officer | Sell | 36,667 | $0 |
| 2026-04-07 | Sarchi Christopher | Chief Commercial Officer | Buy | 50,000 | $0 |
| 2026-04-06 | Sarchi Christopher | Chief Commercial Officer | Sell | 6,500 | $52,065 |
| 2026-02-20 | Astley-Sparke Philip | Director | Sell | 25,000 | $0 |
| 2025-12-19 | Patel Sushil | Chief Executive Officer | Buy | 200,000 | $0 |
| 2025-12-19 | Xynos Konstantinos | Chief Medical Officer | Buy | 60,000 | $0 |
| 2025-12-19 | Hill Emily Luisa | Chief Financial Officer | Buy | 60,000 | $0 |
| 2025-12-19 | Schwendenman Andrew | Chief Accounting Officer | Buy | 10,000 | $0 |
| 2025-12-19 | Sarchi Christopher | Chief Commercial Officer | Buy | 35,000 | $0 |
| 2025-12-11 | Dhingra Kapil | Director | Buy | 3,169 | $5,546 |
| 2025-12-11 | Dhingra Kapil | Director | Sell | 3,169 | $32,958 |
| 2025-12-04 | Patel Sushil | Chief Executive Officer | Sell | 10,000 | $111,300 |
| 2025-11-19 | Xynos Konstantinos | Chief Medical Officer | Sell | 7,248 | $65,957 |
| 2025-11-19 | Sarchi Christopher | Chief Commercial Officer | Sell | 5,208 | $47,393 |
Source: SEC Form 4 filings · as of 2026-06-03